Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2020 Nov;26(11):1983-1994.
doi: 10.1016/j.bbmt.2020.07.027. Epub 2020 Jul 28.

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients

Alpana Waghmare  1 , Maheen Z Abidi  2 , Michael Boeckh  3 , Roy F Chemaly  4 , Sanjeet Dadwal  5 , Zeinab El Boghdadly  6 , Mini Kamboj  7 , Genovefa A Papanicolaou  7 , Steven A Pergam  8 , Zainab Shahid  9
Affiliations
Practice Guideline

Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients

Alpana Waghmare et al. Biol Blood Marrow Transplant. 2020 Nov.

Abstract

There are currently limited data on the epidemiology, clinical manifestations, and optimal management of Coronavirus Disease 2019 (COVID-19) in hematopoietic cell transplantation and cellular therapy recipients. Given the experience with other respiratory viruses, we anticipate that patients may develop severe clinical disease and thus provide the following general principles for cancer centers across the nation. These guidelines were developed by members of the American Society for Transplantation and Cellular Therapy Infectious Diseases Special Interest Group. Specific practices may vary depending on local epidemiology and testing capacity, and the guidance provided in this document may change as new information becomes available.

Keywords: COVID-19; SARS-CoV-2; cellular therapy; hematopoietic cell transplan.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evaluation of HCT and cellular therapy candidates.
Figure 2
Figure 2
Suggested infection prevention practices for bone marrow transplant units.
See this image and copyright information in PMC

References

    1. Ljungman P, Mikulska M, de la Camara R, et al. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy [e-pub ahead of print]. Bone Marrow Transplant. doi: 10.1038/s41409-020-0919-0. - PMC - PubMed
    1. Bachanova V, Bishop MR, Dahi P, et al. Chimeric antigen receptor T cell therapy during the COVID-19 pandemic. Biol Blood Marrow Transplant. 2020;26:1239–1246. - PMC - PubMed
    1. Centers for Disease Control and Prevention. Overview of testing for SARS-CoV-2. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html. Accessed July 20,2020.
    1. Yang Y, Yang M, Shen C, et al. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv. 2020 doi: 10.1101/2020.02.11.20021493. - DOI
    1. Boonyaratanakornkit J, Vivek M, Xie H, et al. Predictive value of respiratory viral detection in the upper respiratory tract for infection of the lower respiratory tract with hematopoietic stem cell transplantation. J Infect Dis. 2020;221:379–388. - PMC - PubMed

Publication types

MeSH terms